24 completed, 3 not yet recruiting, 1 active not recruiting, 1 enrolling by invitation. 9 Not applicable, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 9 | Completed 6, Active not recruiting 1, Not yet recruiting 1, Unknown 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Cepheid: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combating Related Epidemics in HCV Cepheid GeneXpert HCV Test, Abbott Determine HIV - 1/2 Ag/Ab, Abbott Determine HbsAg 2 - HIV - Human Immunodeficiency Virus, Hepatitis B Virus (HBV) | Phase 4 | Not yet recruiting | Duke University | 1280 | 2027-01-20 | 2026-10-15 |
| ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing Xpert HCV Viral Load Finger-stick Point-of-Care test (Cepheid) - Hepatitis C | Not applicable | Not yet recruiting | Johns Hopkins University | 200 | 2026-11-01 | 2025-11-10 |
| Study on Risk Assessment for Patients With Microscopic Hematuria (Non-Visible Blood in Urine) Using a Urine Marker Test Hematuria | Not yet recruiting | Christian Bolenz | 1475 | 2026-03-01 | 2025-12-29 | |
| Xpert® Tropical Fever Test on GeneXpert® Edge X System Xpert Tropical Fever test - Malaria Fever, Zika | Enrolling by invitation | Cepheid | 2500 | 2025-08-18 | 2026-04-09 | |
| Xpert® ERP on the GeneXpert® System Xpert ERP - Respiratory Tract Infections | Completed | Cepheid | 3200 | 2025-05-13 | 2026-03-24 | |
| Xpert® Hemorrhagic Fever on the GeneXpert® Edge X System Xpert Hemorrhagic Fever test - Hemorrhagic Fever | Completed | Cepheid | 408 | 2025-01-13 | 2026-01-27 | |
| Xpert Hemorrhagic Fever on Edge X in Trained and Untrained Users Xpert Hemorrhagic Fever test - Hemorrhagic Fever | Completed | Cepheid | 725 | 2024-10-21 | 2026-05-18 | |
| Point of Care Diagnosis of Vaginal Infections Xpert® Xpress MVP test, Usual Care - Vaginitis, Bacterial Vaginosis | Not applicable | Completed | Sharon L Hillier | 351 | 2024-06-16 | 2026-04-08 |
| Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress System Xpert HCV - HCV | Completed | Cepheid | 1012 | 2024-02-06 | 2024-07-19 | |
| GreenBladder - Early Detection of Bladder Cancer in Residents in Greenland Using a Urinary Marker and a Mobile Cystoscopy Unit Xpert® Bladder Cancer Detection Test - Urinary Bladder Neoplasms | Completed | Jørgen Bjerggaard Jensen | 127 | 2023-12-28 | 2026-03-03 | |
| Leveraging CHWs to Improve COVID-19 Testing and Mitigation Among CJIs Accessing a Corrections-focused CBO Onsite Point-of-care - Covid19 | Not applicable | Completed | Montefiore Medical Center | 250 | 2022-04-14 | 2026-06-25 |
| Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC) Cepheid GeneXpert HIV-1 Qual POC HIV VL test, DPP HIV-Syphilis test system, OraQuick - HIV Infections, Syphilis | Not applicable | Completed | Johns Hopkins University | 224 | 2021-08-18 | 2026-04-23 |
| HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in Brussels GeneXpert HCV VL Fingerstick test - Hepatitis C, Chronic | Completed | Centre Hospitalier Universitaire Saint Pierre | 103 | 2020-11-17 | 2023-05-06 | |
| Surveillance of High-grade Non-muscle Invasive Bladder Tumours Using the Xpert Bladder Cancer Monitor Xpert Bladder Cancer Monitor, Flexible cystoscopy (WL/NBI) and urinary cytology - Non-muscle Invasive Bladder Cancer, Urinary Biomarker | Not applicable | Active not recruiting | Jørgen Bjerggaard Jensen | 392 | 2019-11-01 | 2023-06-01 |
| Xpert MTB/XDR Clinical Evaluation Trial Cepheid Gene Xpert MTB/XDR - Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant | Completed | Foundation for Innovative New Diagnostics, Switzerland | 710 | 2019-07-11 | 2021-05-19 | |
| The Implementation of Real-time PCR - Intrapartum GBS (Group B Streptococcus) Colonization to Reduce Antibiotic Prophylaxis GBS vaginal double swab - GBS | Completed | Carmel Medical Center | 303 | 2019-06-01 | 2020-09-23 | |
| Diagnostic Performance Evaluation Study of the Xpert® Bladder Cancer Monitor Test. Xpert® Bladder Cancer Monitor Test - Non-Invasive Bladder Urothelial Carcinoma, Non-Invasive Bladder Papillary Urothelial Carcinoma, Low Grade | Completed | Clinique Beau Soleil | 320 | 2019-05-22 | 2021-02-09 | |
| Rapid and Accurate Diagnosis of Paediatric TB (RaPaed-AIDA-TB) Sample collection - Tuberculosis, Diagnoses Disease | Completed | Michael Hoelscher | 974 | 2019-01-21 | 2023-05-01 | |
| A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X) Xpert Bladder Cancer Monitor - Non-muscle-invasive Bladder Cancer | Completed | Cepheid | 852 | 2018-06-06 | 2023-02-13 | |
| Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study Xpert bladder cancer monitor - Bladder Cancer | Not applicable | Completed | Mansoura University | 198 | 2018-03-01 | 2019-11-21 |
Showing 20 of 31. Sign in to see all of them.
Non-Muscle Invasive Bladder Neoplasms (4) · Acquired Immunodeficiency Syndrome (3) · Hepatitis C (3) · Urinary Bladder Neoplasms (3) · Chlamydia Infections (2) · Gonorrhea (2) · Hemorrhagic Fevers, Viral (2) · Infections (2) · Sexually Transmitted Diseases (2) · Tuberculosis (2) · Bacteremia (1) · COVID-19 (1) · Candidiasis, Vulvovaginal (1) · Chikungunya Fever (1) · Colitis, Ulcerative (1)
Angptl4 protein, mouse (1) · Blood Specimen Collection (1) · Cathartics (1) · Defecation (1) · Fecal Microbiota Transplantation (1) · Sofosbuvir (1) · Specimen Handling (1) · sofosbuvir-velpatasvir drug combination (1) · velpatasvir (1)
United States (17) · France (3) · Canada (2) · Denmark (2) · Germany (2) · Netherlands (2) · Austria (1) · Belgium (1) · Czechia (1) · Egypt (1) · Greenland (1) · India (1) · Israel (1) · Italy (1) · Malawi (1)
Annie Luetkemeyer, MD (1) · Bernard Malavaud, M.D. (1) · Colleen S Kraft, MD, MSc (1) · Cynthia Firnhaber, MD (1) · Daniel M Musher, MD (1) · Francis A Farraye, MD (1) · Jean-Pierre Mulkay, MD (1) · Jennifer Havens (1) · Larissa May, MD (1) · Lise Meunier, MD (1) · Mark Parta, MD (1) · Matthew Akiyama, MD MSc (1) · Matthew Hamill, MBChB, Ph.D (1) · Michael Hoelscher, Professor (1) · Mohamed Trabelssi, M.D. (1)
PMID 26839383, PMID 27100764, PMID 29074030, PMID 33029623, PMID 34627496, PMID 35990750, PMID 36854097, PMID 37658305, PMID 37910603, PMID 41400951, PMID 41823658, PMID 42117698, PMID 42335913, PMID 42811307
R01MD016744 (1), U01AI195193 (1)